Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QMed is a U.S.-based healthcare technology and disease-management company focused on evidence-based clinical information systems for chronic disease care. Its core offering has been the OHMS/CVD platform, an online health management system designed to support management of cardiovascular disease and related chronic conditions through integrated medical records, predictive tools, and workflow support. Company descriptions in private-market and legacy public-market sources indicate it has also addressed heart failure, diabetes, chronic obstructive pulmonary disease, and weight or obesity management. QMed appears to operate as a commercial healthtech business rather than a therapeutics developer, with its business centered on provider and payer-facing care management infrastructure and services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QMed.